In the context of cisplatin-induced AKI, cisplatin has been observed to disrupt the balance between mitochondrial fusion and fission, leading to a decrease in OPA1 expression and an increase in DRP1 expression [31]. The gene discussed is DNM1L; the disease is acute kidney injury.